Company Overview
- Headquarters
- 160 Second Street Floor 3, Cambridge MA
- Website
- vbivaccines.com
- Phone
- (617) 830-****
- Employees
- 63
- Founded in
- 2001
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:VBI
- NAICS Code
- 325414, 32, 55, 325, 3254, 32541
- SIC Code
- 28, 283
Financials & Stats
Revenue
$3B
Who is VBI Vaccines Inc
VBI Vaccines Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company employs 63 people and generated $3 million in revenue. VBI Vaccines focuses on developing innovative vaccines and immunotherapies. VBI Vaccines specializes in virus-like particle ("VLP") technology, including a proprietary enveloped VLP ("eVLP") platform. Their vaccine candidates are designed to mimic the natural presentation of viruses, stimulating the human immune system to fight diseases. The company's pipeline targets a range of diseases, including hepatitis B, COVID-19 and coronaviruses, cytomegalovirus (CMV), and aggressive cancers like glioblastoma (GBM). Research operations for VBI Vaccines are located in Ottawa, Canada, and the company maintains a research and manufacturing site in Rehovot, Israel. For more information, visit www.vbivaccines.com. News and insights can be found at www.vbivaccines.com/news-and-resources/, investor information is available at www.vbivaccines.com/investors/, and job opportunities are listed at www.vbivaccines.com/careers/.
Company Leadership
VBI Vaccines Inc Industry Tags
VBI Vaccines Inc Tech Stack
Companies Similar to VBI Vaccines Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to VBI Vaccines Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 6 | Davis, CA | 2016 | |
| 3M | 28 | 2005 | ||
| 3M | 4 | Oakland, CA | 2012 | |
| 3M | 5 | Del Mar, CA | 2017 | |
| 3M | 42 | Westlake Village, CA | 2010 |